SCHEMBL7990063

SCHEMBL7990063

Cn1cnc2nc[nH]c(=O)c21.Cn1cnc2nc[nH]c(=O)c21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
GDA Q9Y2T3 2/20 0.44
CYP3A4 P08684 2/20 0.43
PMP22 Q01453 2/20 0.43
MAPK1 P28482 1/20 0.43
BRD4 O60885 2/20 0.42
RAB9A P51151 3/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 2/20 0.40
TSHR P16473 2/20 0.40
BLM P54132 2/20 0.40
MAPT P10636 1/20 0.40
ADORA2A P29274 3/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PIK3CD O00329 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2414856 1.00 ALDH1A1 (0.47) ALDH1A1GDACYP3A4PMP22MAPK1
Hydrochloric Acid SCHEMBL29540090 0.98 ALDH1A1 (0.45) ALDH1A1GDACYP3A4PMP22MAPK1
SCHEMBL20187696 0.87 ALDH1A1 (0.42) ALDH1A1GDACYP3A4PMP22MAPK1
SCHEMBL20189112 0.83 ALDH1A1 (0.45) ALDH1A1GDABRD4RAB9APOLB
SCHEMBL21353906 0.81 GDA (0.42) ALDH1A1GDACYP3A4PMP22MAPK1
SCHEMBL1866524 0.78 ADORA2A (0.50) ALDH1A1POLBBLMADORA2APDE4A
SCHEMBL25100643 0.77 ADORA2A (0.47) ALDH1A1BRD4RAB9APOLBLMNA
SCHEMBL7046793 0.75 ALDH1A1 (0.41) ALDH1A1BRD4RAB9APOLBLMNA
Guanine SCHEMBL21840391 0.73 PNP (0.68) ALDH1A1GDACYP3A4PMP22MAPK1
SCHEMBL2115743 0.73 ALDH1A1 (0.52) ALDH1A1CYP3A4PMP22LMNABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed